PHARMACOKINETICS AND BIOAVAILABILITY OF TICARCILLIN AND CLAVULANATE IN FOALS AFTER INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION

被引:8
|
作者
WILSON, WD
SPENSLEY, MS
BAGGOT, JD
HIETALA, SK
PRYOR, P
机构
[1] UNIV CALIF DAVIS,DEPT VET PHARMACOL,DEPT VET PHARMACOL & TOXICOL,DAVIS,CA 95616
[2] UNIV CALIF DAVIS,VET MED TEACHING HOSP,SCH VET MED,DAVIS,CA 95616
关键词
D O I
10.1111/j.1365-2885.1991.tb00807.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics and bioavailability of ticarcillin and clavulanate were determined after intravenous (i.v.) or intramuscular (i.m.) administration of ticarcillin disodium (50 mg/kg) combined with clavulanate potassium (1.67 mg/kg) to groups of healthy foals at 3 days and 28 days of age. After i.v. administration of the combination to five foals, the disposition kinetics of ticarcillin and clavulanate were best described using a two-compartment open model. Mean plasma elimination-rate constant (beta) and clearance (Cl(B)) for ticarcillin were significantly less (P < 0.01), and volume of distribution at steady state (V(d)(ss)) was significantly larger (P < 0.05), in the foals at 3 days compared with 28 days of age. This indicated that renal excretion mechanisms were immature and ticarcillin was more widely distributed in 3-day-old foals. The mean elimination rate constant for clavulanate was significantly less (P < 0.01) at 3 days than at 28 days of age. Values of the major kinetic terms describing the disposition of ticarcillin after i.m. administration to five 3-day-old foals were not significantly different from values of these parameters in the same foals at 28 days of age. After i.m. administration of the drug combination, plasma clavulanate concentrations peaked significantly later (P < 0.01), and the elimination-rate constant (k(d)) for clavulanate was significantly less (P < 0.01), in 3-day-old foals than in 28-day-old foals. The bioavailabilities of ticarcillin and clavulanate after i.m. administration in 3-day-old foals were 100% and 88.3%, respectively, and in 28-day-old foals were 100% and 27.4%, respectively. Mean plasma ticarcillin concentrations exceeded 16-mu-g/ml for a longer period after i.m. administration of the drug combination than after i.v. administration to foals of both age groups. By virtue of the frequency of administration required and the painful response eleicited by i.m. injection, it is recommended that when the combination of ticarcillin disodium (50 mg/kg) and clavulanate potassium (1.67 mg/kg) is used in foals to treat infections caused by susceptible organisms (MIC less-than-or-equal-to 16-mu-g/ml), it should be administered i.v. four times daily.
引用
收藏
页码:78 / 89
页数:12
相关论文
共 50 条
  • [31] Flumequine in the Goat: Pharmacokinetics after Intravenous and Intramuscular Administration
    R. Villa
    P. Cagnardi
    O. Sonzogni
    S. Carli
    Veterinary Research Communications, 2005, 29 : 689 - 698
  • [32] Flumequine in the goat: Pharmacokinetics after intravenous and intramuscular administration
    Villa, R
    Cagnardi, P
    Sonzogni, O
    Carli, S
    VETERINARY RESEARCH COMMUNICATIONS, 2005, 29 (08) : 689 - 698
  • [33] Pharmacokinetics of azythromycin after intravenous and intramuscular administration to goats
    Espuny, A.
    Carceles, C. M.
    Escudero, E.
    Marin, P.
    Fernandez-Varon, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 99 - 99
  • [34] Pharmacokinetics of butafosfan after intravenous and intramuscular administration in piglets
    Sun, F.
    Wang, J.
    Yang, S.
    Zhang, S.
    Shen, J.
    Xingyuan, C.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2017, 40 (02) : 203 - 205
  • [35] Pharmacokinetics of indomethacin in sheep after intravenous and intramuscular administration
    Vinagre, E
    Rodriguez, C
    San Andres, MI
    Boggio, JC
    San Andres, MD
    Encinas, T
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1998, 21 (04) : 309 - 314
  • [36] THE PHARMACOKINETICS OF TICARCILLIN CLAVULANATE ACID IN NEONATES
    FRICKE, G
    DOERCK, M
    HAFNER, D
    HORTON, R
    KRESKEN, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 : 111 - 120
  • [37] PHARMACOKINETICS AND BIOAVAILABILITY OF INJECTED GLUCAGON - DIFFERENCES BETWEEN INTRAMUSCULAR, SUBCUTANEOUS, AND INTRAVENOUS ADMINISTRATION
    MUHLHAUSER, I
    KOCH, J
    BERGER, M
    DIABETES CARE, 1985, 8 (01) : 39 - 42
  • [38] PHARMACOKINETICS AND BIOAVAILABILITY OF A NEW FORMULATION OF TEICOPLANIN FOLLOWING INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION TO HUMANS
    ANTONY, KK
    LEWIS, EW
    KENNY, MT
    DULWORTH, JK
    BRACKMAN, MB
    KUZMA, R
    YUH, L
    ELLER, MG
    THOMPSON, GA
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (06) : 605 - 607
  • [39] PHARMACOKINETICS AND BIOAVAILABILITY OF INJECTED GLUCAGON - DIFFERENCES BETWEEN SUBCUTANEOUS, INTRAMUSCULAR AND INTRAVENOUS ADMINISTRATION
    MUHLHAUSER, I
    KOCH, J
    BERGER, M
    DIABETOLOGIA, 1984, 27 (02) : A313 - A313
  • [40] Pharmacokinetics and bioavailability of meloxicam in Pekin ducks following intravenous, intramuscular and oral administration
    Coskun, Devran
    Corum, Orhan
    Corum, Duygu Durna
    Uney, Kamil
    VETERINARY ANAESTHESIA AND ANALGESIA, 2023, 50 (06) : 477 - 484